Fifth Third Bancorp
AGIO icon

Fifth Third Bancorp’s Agios Pharmaceuticals AGIO Stock Holding History

Fifth Third Bancorp’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Buy
281
+72
+34% +$2.18K ﹤0.01% 3734
2026
Q1 		$7.09K Buy
+209
New +$5.93K ﹤0.01% 3776
2025
Q4 		– Sell
-30
Closed -$1.2K – 2634
2025
Q3 		$1.2K Buy
+30
New +$1.13K ﹤0.01% 2511
2018
Q4 		– Sell
-83
Closed -$6K – 2213
2018
Q3 		$6K Sell
83
-72
-46% -$5.79K ﹤0.01% 1936
2018
Q2 		$13K Hold
155
– – ﹤0.01% 1790
2018
Q1 		$13K Hold
155
– – ﹤0.01% 1804
2017
Q4 		$9K Sell
155
-534
-78% -$33.6K ﹤0.01% 1841
2017
Q3 		$46K Buy
+689
New +$41.4K ﹤0.01% 1308
2015
Q4 		– Sell
-84
Closed -$6K – 2723
2015
Q3 		$6K Buy
+84
New +$8.21K ﹤0.01% 2203

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Fifth Third Bancorp's AGIO Position: Q2 2026 in Review

Fifth Third Bancorp increased its Agios Pharmaceuticals (AGIO) stake by 34% in Q2 2026, buying an estimated $2.18K and bringing the position to 281 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

Fifth Third Bancorp first reported a position in AGIO in Q3 2015 and has held it in 9 quarters since. The position peaked at $46K in Q3 2017. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Fifth Third Bancorp held 281 shares of Agios Pharmaceuticals worth $10.4K as of Q2 2026.
  • Fifth Third Bancorp bought 72 Agios Pharmaceuticals shares in Q2 2026, an estimated $2.18K.
  • Agios Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3734 holding.
  • Fifth Third Bancorp first reported a position in Agios Pharmaceuticals in Q3 2015 and has held it in 9 quarters since.
  • Fifth Third Bancorp's Agios Pharmaceuticals position peaked at $46K in Q3 2017.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.